For future studies, we can incorporate the IDH status to the prediction model for the MGMT methylation in diffuse gliomas because IDH-wildtype and IDH-mutant group shows different tumor biology, although they are classified as adult-type diffuse gliomas, which might lead to different diagnostic performance of MGMT methylation. This evidence concerns the gene MGMT and neoplasm.